Expert Opinion on Therapeutic Targets, Volume 23, Issue 7 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Therapeutic Targets, Volume 23, Issue 7 (2019)

See all volumes and issues
Vol 28, 2024 Vol 27, 2023 Vol 26, 2022 Vol 25, 2021 Vol 24, 2020 Volume 23, 2019 Vol 22, 2018 Vol 21, 2017 Vol 20, 2016 Vol 19, 2015 Vol 18, 2014 Vol 17, 2013 Vol 16, 2012 Vol 15, 2011 Vol 14, 2010 Vol 13, 2009 Vol 12, 2008 Vol 11, 2007 Vol 10, 2006 Vol 9, 2005 Vol 8, 2004 Vol 7, 2003 Vol 6, 2002 Vol 5, 2001 Vol 5, 2001 Vol 4, 2000 Vol 3, 1999 Vol 2, 1998 Vol 1, 1997
Download citations Download PDFs Download issue

Editorial

Article
ASCT2: a potential cancer drug target
Kanu Wahi & Jeff Holst
Pages: 555-558
Published online: 04 Jun 2019
First Page PreviewforASCT2: a potential cancer drug target | Full Text | References | PDF (564.7 KB) | EPUB
  • 885 Views
  • 23 CrossRef citations
  • 0Altmetric
Article
Shedding light on RNaseH: a promising target for hepatitis B virus (HBV)
Tiffany C. Edwards, Nathan L. Ponzar & John E. Tavis
Pages: 559-563
Published online: 22 May 2019
First Page PreviewforShedding light on RNaseH: a promising target for hepatitis B virus (HBV) | Full Text | References | PDF (749.7 KB) | EPUB
  • 161 Views
  • 10 CrossRef citations
  • 0Altmetric

Review

Review
Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Maïka Jangal, Benjamin Lebeau & Michael Witcher
Pages: 565-578
Published online: 10 Jun 2019
AbstractforBeyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy? | Full Text | References | PDF (1.5 MB) | EPUB
  • 553 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Annabelle M. Warren, Søren T. Knudsen & Mark E. Cooper
Pages: 579-591
Published online: 03 Jun 2019
AbstractforDiabetic nephropathy: an insight into molecular mechanisms and emerging therapies | Full Text | References | PDF (981.7 KB) | EPUB
  • 2540 Views
  • 132 CrossRef citations
  • 0Altmetric
Article
A preclinical overview of emerging therapeutic targets for glomerular diseases
Paola Cassis, Carlamaria Zoja, Luca Perico & Giuseppe Remuzzi
Pages: 593-606
Published online: 12 Jun 2019
AbstractforA preclinical overview of emerging therapeutic targets for glomerular diseases | Full Text | References | PDF (1.5 MB) | EPUB
  • 358 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Visfatin as a therapeutic target for rheumatoid arthritis
Eloi Franco-Trepat, Ana Alonso-Pérez, María Guillán-Fresco, Alberto Jorge-Mora, Oreste Gualillo, Juan J. Gómez-Reino & Rodolfo Gómez Bahamonde
Pages: 607-618
Published online: 15 May 2019
AbstractforVisfatin as a therapeutic target for rheumatoid arthritis | Full Text | References | PDF (1.9 MB) | EPUB
  • 338 Views
  • 25 CrossRef citations
  • 0Altmetric

Original Research

Article
An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients
Marcelino Bermudez-Lopez, Carles Forne, Nuria Amigo, Milica Bozic, David Arroyo, Teresa Bretones, Nuria Alonso, Serafi Cambray, Maria Dolores Del Pino, Didac Mauricio, Jose Luis Gorriz, Elvira Fernandez, Jose Manuel Valdivielso & on behalf of the NEFRONA investigators
Pages: 619-630
Published online: 23 May 2019
AbstractforAn in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients | Full Text | References | PDF (6.5 MB) | EPUB
  • 541 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Genome-wide bioinformatics analysis of FMN, SAM-I, glmS, TPP, lysine, purine, cobalamin, and SAH riboswitches for their applications as allosteric antibacterial drug targets in human pathogenic bacteria
Nikolet Pavlova & Robert Penchovsky
Pages: 631-643
Published online: 14 May 2019
AbstractforGenome-wide bioinformatics analysis of FMN, SAM-I, glmS, TPP, lysine, purine, cobalamin, and SAH riboswitches for their applications as allosteric antibacterial drug targets in human pathogenic bacteria | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 520 Views
  • 18 CrossRef citations
  • 0Altmetric

Correction

Correction
Correction
Page: 645
Published online: 07 Jun 2019
CitationforCorrection | Full Text | PDF (100.8 KB) | EPUB
  • 428 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Ways of modulating GABA transporters to treat neurological disease
Jonas S. Mortensen et al.
Review Article | Published online: 27 Jul 2024
Open Access
Antibacterial carbonic anhydrase inhibitors targeting Vibrio cholerae enzymes
Mohammad Sadegh Gheibzadeh et al.
Review Article | Published online: 19 Jul 2024
The role of adipokines in the pathogenesis of psoriasis – a focus on resistin, omentin-1 and vaspin
Kajetan Kiełbowski et al.
Review Article | Published online: 5 Jul 2024
Pathways and targeting avenues of BRAF in non-small cell lung cancer
Evgeny N. Imyanitov et al.
Review Article | Published online: 4 Jul 2024
View all latest articles